Special feature: pathological case of the month. Glycogen storage disease with renal tubular dysfunction (type XI, Fanconi-Bickel syndrome).
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI.
Trepiccione F, Iervolino A, D'Acierno M, Siccardi S, Costanzo V, Sardella D, De La Motte LR, D'Apolito L, Miele A, Perna AF, Capolongo G, Zacchia M, Frische S, Nielsen R, Staiano L, Sambri I, De Cegli R, Unwin R, Eladari D, Capasso G.
Sci Transl Med. 2023 Nov;15(720):eabn4214. doi: 10.1126/scitranslmed.abn4214. Epub 2023 Nov 1.
Fanconi Syndrome.
Foreman JW.
Pediatr Clin North Am. 2019 Feb;66(1):159-167. doi: 10.1016/j.pcl.2018.09.002.
Inherited Fanconi syndrome.
Albuquerque ALB, Dos Santos Borges R, Conegundes AF, Dos Santos EE, Fu FMM, Araujo CT, Vaz de Castro PAS, Simões E Silva AC.
World J Pediatr. 2023 Jul;19(7):619-634. doi: 10.1007/s12519-023-00685-y. Epub 2023 Feb 2.
[Fanconi syndrome].
Velásquez-Jones L.
Bol Med Hosp Infant Mex. 1987 Sep;44(9):509-10.
Drug-induced Fanconi's syndrome.
Izzedine H, Launay-Vacher V, Isnard-Bagnis C, Deray G.
Am J Kidney Dis. 2003 Feb;41(2):292-309. doi: 10.1053/ajkd.2003.50037.
Drug-induced renal Fanconi syndrome.
Hall AM, Bass P, Unwin RJ.
QJM. 2014 Apr;107(4):261-9. doi: 10.1093/qjmed/hct258. Epub 2013 Dec 24.
Therapy of cystinosis.
Schneider JA.
N Engl J Med. 1985 Dec 5;313(23):1473-4. doi: 10.1056/NEJM198512053132309.
[Fanconi syndrome].
Ueda Y, Yamada T, Ibuka K.
Nihon Ishikai Zasshi. 1971 Mar 15;65(6):740-8.
[Fanconi syndrome].
Igarashi T.
Ryoikibetsu Shokogun Shirizu. 1997;(16 Pt 1):605-11.
Extrarenal complications of cystinosis.
Topaloglu R.
Pediatr Nephrol. 2024 Aug;39(8):2283-2292. doi: 10.1007/s00467-023-06225-0. Epub 2023 Dec 21.
